Bank of Montreal
BMO
Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
4
Canadian Imperial Bank of Commerce
CM
5
Bank of Nova Scotia
BNS
CA Stock MarketDetailed Quotes
MRVL Marvel Biosciences Corp
- 0.100
- -0.010-9.09%
15min DelayMarket Closed Apr 24 16:00 ET
4.48MMarket Cap-2.50P/E (TTM)
0.110High0.100Low6.00KVolume0.110Open0.110Pre Close630.00Turnover0.18052wk High0.02%Turnover Ratio44.80MShares0.06052wk Low-0.04EPS TTM3.67MFloat Cap0.390Historical HighLossP/E (Static)36.73MShs Float0.010Historical Low-0.04EPS LYR9.09%Amplitude--Dividend TTM-1.27P/B1Lot Size--Div YieldTTM
Marvel Biosciences Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 88.98%-26.38K | -9.53%-262.48K | 11.46%-1.18M | 23.57%-340.57K | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K |
| Net income from continuing operations | -108.58%-485.61K | 46.32%-278.25K | 27.99%-1.65M | 43.43%-591.65K | 57.10%-307.31K | 0.08%-232.81K | -74.98%-518.3K | 10.29%-2.29M | -79.74%-1.05M | -82.61%-716.33K |
| Remuneration paid in stock | 166.37%18.79K | 121.62%21.48K | -5.49%75.72K | 294.05%54.47K | -66.33%4.5K | -64.84%7.05K | -70.50%9.69K | --80.12K | --13.82K | --13.37K |
| Other non cashItems | ---- | ---- | --210K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 3,349.71%440.43K | -102.13%-5.72K | -78.97%184.86K | -102.25%-13.38K | -114.34%-57.17K | 45.07%-13.55K | 400.24%268.97K | 144.14%879.04K | 331.63%594.67K | 125.95%398.63K |
| -Change in receivables | 0.11%-8.29K | 17.14%-8.92K | 116.63%4.24K | 339.62%30.08K | 25.05%-6.79K | 30.06%-8.3K | -234.49%-10.76K | -1,054.87%-25.48K | -48.50%-12.55K | -137.43%-9.06K |
| -Change in prepaid assets | 20.56%-5.9K | 3.85%9.1K | -114.78%-34.01K | -140.08%-46.05K | -91.88%10.7K | 71.22%-7.43K | -4.16%8.76K | 192.70%230.04K | 147.70%114.9K | 1,908.12%131.81K |
| -Change in payables and accrued expense | 20,840.63%454.62K | -102.18%-5.9K | -68.18%214.64K | -99.48%2.58K | -122.14%-61.08K | -83.30%2.17K | 353.88%270.96K | 11.39%674.47K | 27.19%492.32K | 72.95%275.88K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 88.98%-26.38K | -9.53%-262.48K | 11.46%-1.18M | 23.57%-340.57K | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -25.24%968.64K | 468.64K | 0 | 228.85%1.3M | 0 | 1M | ||||
| Net issuance payments of debt | ---- | ---- | -50.00%500K | --0 | --0 | ---- | ---- | --1M | --0 | --1M |
| Net common stock issuance | ---- | ---- | 85.19%500K | 1,766.67%500K | ---- | ---- | ---- | -35.71%270K | -107.14%-30K | --0 |
| Net other financing activities | ---- | ---- | -222.25%-31.36K | ---- | ---- | ---- | ---- | 198.65%25.65K | --30K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -25.24%968.64K | --468.64K | --0 | ---- | ---- | 228.85%1.3M | --0 | --1M |
| Net cash flow | ||||||||||
| Beginning cash position | -73.72%83.29K | -37.88%345.77K | -6.17%556.62K | -78.28%217.69K | 93.64%577.67K | -40.85%316.98K | -6.17%556.62K | -75.21%593.21K | 55.78%1M | -65.28%298.33K |
| Current changes in cash | -109.11%-23.76K | -9.53%-262.48K | -476.34%-210.85K | 128.75%128.08K | -151.14%-359.98K | 209.72%260.69K | -318.37%-239.64K | 97.97%-36.59K | -789.12%-445.56K | 426.08%703.86K |
| End cash Position | -89.69%59.53K | -73.72%83.29K | -37.88%345.77K | -37.88%345.77K | -78.28%217.69K | 93.64%577.67K | -40.85%316.98K | -6.17%556.62K | -6.17%556.62K | 55.78%1M |
| Free cash from | 88.98%-26.38K | -9.53%-262.48K | 11.46%-1.18M | 23.57%-340.57K | -21.56%-359.98K | -0.72%-239.31K | 32.10%-239.64K | 39.28%-1.33M | -0.33%-445.56K | -37.19%-296.14K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.
Unlock Now